Imunon News

HC Wainwright & Co. : Maintaining the Imunon (IMNN.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $13.00 to $12.00.

Zhitong FinanceMay 14 19:02

Imunon Analyst Ratings

BenzingaMay 14 18:57

HC Wainwright & Co. Maintains Buy on Imunon, Lowers Price Target to $12

BenzingaMay 14 19:00

Imunon's Promising Clinical Trials and Strategic Advances Merit a Buy Rating

TipRanksMay 14 18:26

Imunon Analyst Ratings

BenzingaApr 1 19:17

HC Wainwright & Co. Maintains Buy on Imunon, Raises Price Target to $13

BenzingaApr 1 19:18

Analysts Offer Insights on Healthcare Companies: Daré Bioscience (DARE), Legend Biotech (LEGN) and Imunon (IMNN)

TipRanksApr 1 18:20

Imunon Analyst Ratings

BenzingaMar 14 00:39

Analysts Offer Insights on Healthcare Companies: Imunon (IMNN) and CalciMedica (CALC)

TipRanksMar 14 00:30

Positive Interim OVATION 2 Data Bolsters Confidence in Imunon Stock: An Analysis of Emily Bodnar's Buy Rating

TipRanksNov 15, 2023 01:35

Analysts Have Conflicting Sentiments on These Healthcare Companies: Imunon (IMNN) and Laboratory (LH)

TipRanksSep 15, 2023 23:40

HC Wainwright & Co. Reiterates Buy on Imunon, Maintains $12 Price Target

BenzingaSep 15, 2023 23:38

Imunon Analyst Ratings

BenzingaSep 15, 2023 23:37

Imunon Analyst Ratings

BenzingaAug 11, 2023 22:27

H.C. Wainwright Reaffirms Their Buy Rating on Imunon (IMNN)

TipRanksAug 11, 2023 18:25

Imunon (IMNN) Receives a Buy From H.C. Wainwright

TipRanksMay 12, 2023 18:25